Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection
<p><strong>Background</strong> A synergistic effect of combination therapy with favipiravir and oseltamivir has been reported in preclinical models of influenza. However, no data are available on the clinical effectiveness of combination therapy in severe influenza.</p> <...
Main Authors: | Wang, Y, Fan, G, Salam, A, Horby, P, Hayden, F, Chen, C, Pan, J, Zheng, J, Lu, B, Guo, L, Wang, C, Cao, B, Cap-China Network |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Oxford University Press
2019
|
Registos relacionados
-
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
Por: Wang, Y, et al.
Publicado em: (2020) -
Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
Por: Parvaiz A Koul, et al.
Publicado em: (2024-01-01) -
Does Oseltamivir Really Reduce Complications of Influenza?
Por: Del Mar, C, et al.
Publicado em: (2011) -
Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
Por: Chairat, K, et al.
Publicado em: (2016) -
Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023
Por: Mihai Maria Elena, et al.
Publicado em: (2024-04-01)